Monte Rosa Therapeutics Newsroom

J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $15

Futu NewsNov 9 11:31

Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $14

Futu NewsNov 8 18:31

TD Cowen Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating

Futu NewsNov 8 03:31

Optimistic Outlook and Buy Rating on Monte Rosa Therapeutics Due to Promising Clinical Progress and Strategic Collaborations

TipRanksNov 8 03:30

Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $17

Futu NewsOct 29 19:31

Monte Rosa Therapeutics Price Target Maintained With a $11.00/Share by Wedbush

Dow JonesSep 12 20:51

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Immunovant (IMVT) and Monte Rosa Therapeutics (GLUE)

TipRanksAug 13 20:25

Monte Rosa Therapeutics Analyst Ratings

BenzingaAug 13 01:41

Buy Rating Affirmed: Anticipated Catalysts and Undervaluation Set to Boost Monte Rosa Therapeutics

TipRanksAug 12 18:43

TD Cowen Keeps Their Buy Rating on Monte Rosa Therapeutics (GLUE)

TipRanksAug 9 08:20

Piper Sandler Reiterates Overweight on Monte Rosa Therapeutics, Maintains $16 Price Target

BenzingaJun 29 01:37

Monte Rosa Therapeutics Analyst Ratings

BenzingaJun 29 01:37

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Immunovant (IMVT) and Monte Rosa Therapeutics (GLUE)

TipRanksMay 30 19:53

Monte Rosa Therapeutics Analyst Ratings

BenzingaMay 22 22:56

Wedbush Reiterates Outperform on Monte Rosa Therapeutics, Maintains $11 Price Target

BenzingaMay 22 22:55

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Aerovate Therapeutics (AVTE)

TipRanksMay 22 20:40

Buy Rating Affirmed for Monte Rosa Therapeutics Amidst Promising Drug Pipeline and Stable Financials

TipRanksMay 10 17:25

UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating

MT NewswiresApr 29 22:44

Monte Rosa Therapeutics (GLUE) Gets a Buy From Piper Sandler

TipRanksApr 9 19:10

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Moderna (MRNA) and Monte Rosa Therapeutics (GLUE)

TipRanksMar 19 20:15